Jan Jacobsen

712 total citations
12 papers, 589 citations indexed

About

Jan Jacobsen is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Cancer Research. According to data from OpenAlex, Jan Jacobsen has authored 12 papers receiving a total of 589 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 8 papers in Pulmonary and Respiratory Medicine and 5 papers in Cancer Research. Recurrent topics in Jan Jacobsen's work include Renal cell carcinoma treatment (8 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jan Jacobsen is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Angiogenesis and VEGF in Cancer (8 papers) and Cancer, Hypoxia, and Metabolism (3 papers). Jan Jacobsen collaborates with scholars based in Sweden, United States and Finland. Jan Jacobsen's co-authors include Börje Ljungberg, Kjell Grankvist, Torgny Rasmuson, T. Rasmuson, Anders Bergh, Göran Landberg, Gudrun Lindh, Tommy Olsson, Stina Häggström Rudolfsson and Ulf‐Håkan Stenman and has published in prestigious journals such as The Journal of Urology, European Journal of Cancer and British Journal of Urology.

In The Last Decade

Jan Jacobsen

12 papers receiving 575 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jan Jacobsen Sweden	10	436	384	264	137	48	12	589
Silvia Bombelli Italy	12	366 0.8×	287 0.7×	187 0.7×	105 0.8×	61 1.3×	22	603
L. Wood United States	12	254 0.6×	333 0.9×	126 0.5×	185 1.4×	25 0.5×	23	481
B Torsello Italy	11	350 0.8×	281 0.7×	177 0.7×	69 0.5×	119 2.5×	19	612
Omi Parikh United Kingdom	11	306 0.7×	461 1.2×	224 0.8×	226 1.6×	89 1.9×	34	590
Shinji Nakamichi Japan	13	238 0.5×	268 0.7×	88 0.3×	281 2.1×	44 0.9×	51	566
Charis Kalogirou Germany	14	341 0.8×	229 0.6×	324 1.2×	122 0.9×	100 2.1×	54	654
Robert C. Whorf United States	10	346 0.8×	477 1.2×	200 0.8×	418 3.1×	38 0.8×	20	790
Ecaterina Ileana France	6	335 0.8×	177 0.5×	116 0.4×	192 1.4×	76 1.6×	9	567
Woo Sun Kwon South Korea	16	267 0.6×	271 0.7×	128 0.5×	401 2.9×	89 1.9×	51	677
James A. Onori United States	4	254 0.6×	236 0.6×	123 0.5×	224 1.6×	17 0.4×	5	500

Countries citing papers authored by Jan Jacobsen

Since Specialization

Citations

This map shows the geographic impact of Jan Jacobsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Jacobsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Jacobsen more than expected).

Fields of papers citing papers by Jan Jacobsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Jacobsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Jacobsen. The network helps show where Jan Jacobsen may publish in the future.

Co-authorship network of co-authors of Jan Jacobsen

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Jacobsen. A scholar is included among the top collaborators of Jan Jacobsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Jacobsen. Jan Jacobsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ljungberg, Börje, Jan Jacobsen, Stina Häggström Rudolfsson, et al.. (2006). Different vascular endothelial growth factor (VEGF), VEGF‐receptor 1 and ‐2 mRNA expression profiles between clear cell and papillary renal cell carcinoma. British Journal of Urology. 98(3). 661–667. 46 indexed citations

Jacobsen, Jan, Kjell Grankvist, Torgny Rasmuson, & Börje Ljungberg. (2006). Different isoform patterns for vascular endothelial growth factor between clear cell and papillary renal cell carcinoma. British Journal of Urology. 97(5). 1102–1108. 26 indexed citations

Jacobsen, Jan. (2006). Vascular endothelial growth factor in renal cell carcinoma. KTH Publication Database DiVA (KTH Royal Institute of Technology). 1 indexed citations

Jacobsen, Jan, Kjell Grankvist, T. Rasmuson, et al.. (2004). Expression of vascular endothelial growth factor protein in human renal cell carcinoma. British Journal of Urology. 93(3). 297–302. 146 indexed citations

Rasmuson, Torgny, Kjell Grankvist, Jan Jacobsen, Tommy Olsson, & Börje Ljungberg. (2004). Serum insulin-like growth factor-1 is an independent predictor of prognosis in patients with renal cell carcinoma. Acta Oncologica. 43(8). 744–748. 54 indexed citations

Ljungberg, Börje, et al.. (2003). Tumour vascular endothelial growth factor (VEGF) mRNA in relation to serum VEGF protein levels and tumour progression in human renal cell carcinoma. Urological Research. 31(5). 335–340. 34 indexed citations

Jacobsen, Jan, Kjell Grankvist, T. Rasmuson, & Börje Ljungberg. (2002). Prognostic importance of serum vascular endothelial growth factor in relation to platelet and leukocyte counts in human renal cell carcinoma. European Journal of Cancer Prevention. 11(3). 245–252. 22 indexed citations

Rasmuson, T., Kjell Grankvist, Jan Jacobsen, & Börje Ljungberg. (2001). Impact of serum basic fibroblast growth factor on prognosis in human renal cell carcinoma. European Journal of Cancer. 37(17). 2199–2203. 23 indexed citations

Paju, Annukka, et al.. (2001). TUMOR ASSOCIATED TRYPSIN INHIBITOR AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. The Journal of Urology. 959–962. 2 indexed citations

10.

Paju, Annukka, Jan Jacobsen, Torgny Rasmuson, Ulf‐Håkan Stenman, & Börje Ljungberg. (2001). TUMOR ASSOCIATED TRYPSIN INHIBITOR AS A PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. The Journal of Urology. 165(3). 959–962. 32 indexed citations

11.

Jacobsen, Jan, Torgny Rasmuson, Kjell Grankvist, & Börje Ljungberg. (2000). VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. The Journal of Urology. 163(1). 343–347. 194 indexed citations

12.

Jacobsen, Jan, et al.. (2000). VASCULAR ENDOTHELIAL GROWTH FACTOR AS PROGNOSTIC FACTOR IN RENAL CELL CARCINOMA. The Journal of Urology. 343–343. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact